Interactors | Protein name | Directionality | Classification | |
|---|---|---|---|---|
| 1 | ADM-CALCRL+GPER1+RAMP3 | ADML_HUMAN - | Ligand-Receptor | Signaling by Adrenomedullin |
| 2 | AKR1C3-PTGFR | - PF2R_HUMAN | Ligand-Receptor | Signaling by Prostaglandin |
| 3 | ALDH1A1-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 4 | ALDH1A1-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 5 | ALDH1A1-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 6 | ALDH1A1-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 7 | ALDH1A1-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 8 | ALDH1A1-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 9 | ALDH1A1-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 10 | ALDH1A1-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 11 | ALDH1A1-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 12 | ALDH1A2-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 13 | ALDH1A2-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 14 | ALDH1A2-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 15 | ALDH1A2-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 16 | ALDH1A2-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 17 | ALDH1A2-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 18 | ALDH1A2-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 19 | ALDH1A2-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 20 | ALDH1A2-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 21 | ALDH1A3-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 22 | ALDH1A3-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 23 | ALDH1A3-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 24 | ALDH1A3-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 25 | ALDH1A3-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 26 | ALDH1A3-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 27 | ALDH1A3-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 28 | ALDH1A3-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 29 | ALDH1A3-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
| 30 | ALOX12-FPR2 | - FPR2_HUMAN | Ligand-Receptor | Signaling by Lipoxin/Leukotriene |
| 31 | ANXA1-FPR1 | ANXA1_HUMAN - FPR1_HUMAN | Ligand-Receptor | Signaling by Annexin |
| 32 | ANXA1-FPR2 | ANXA1_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by Annexin |
| 33 | APP-CD74 | A4_HUMAN - HG2A_HUMAN | Ligand-Receptor | Signaling by Amyloid-beta precursor protein |
| 34 | APP-FPR2 | A4_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by Amyloid-beta precursor protein |
| 35 | BMP10-ACVR2A+ACVRL1 | BMP10_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 36 | CALCA-CALCRL+RAMP1 | CALC_HUMAN - | Ligand-Receptor | Signaling by Calcitonin |
| 37 | CCL3-CCR1 | CCL3_HUMAN - CCR1_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 38 | CCL3-CCR3 | CCL3_HUMAN - CCR3_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 39 | CCL3-CCR5 | CCL3_HUMAN - CCR5_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 40 | CCL5-CCR1 | CCL5_HUMAN - CCR1_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 41 | CCL5-CCR3 | CCL5_HUMAN - CCR3_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 42 | CCL5-CCR5 | CCL5_HUMAN - CCR5_HUMAN | Ligand-Receptor | Signaling by Chemokines |
| 43 | CD1D-LILRB2 | CD1D_HUMAN - LIRB2_HUMAN | Ligand-Receptor | |
| 44 | COL1A1-ITGA10+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
| 45 | COL1A1-ITGA11+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
| 46 | COL1A1-ITGA1+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
| 47 | COL1A1-ITGA2+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
| 48 | CTSG-FPR1 | CATG_HUMAN - FPR1_HUMAN | Ligand-Receptor | Signaling by Cathepsin |
| 49 | DAGLA-CNR1 | - CNR1_HUMAN | Ligand-Receptor | Signaling by Arachidonoylglycerol |
| 50 | DAGLA-CNR2 | - CNR2_HUMAN | Ligand-Receptor | Signaling by Arachidonoylglycerol |
| 51 | DBH+SLC18A1-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 52 | DBH+SLC18A1-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 53 | DBH+SLC18A1-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 54 | DBH+SLC18A1-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 55 | DBH+SLC18A2-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 56 | DBH+SLC18A2-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 57 | DBH+SLC18A2-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 58 | DBH+SLC18A2-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 59 | DBH+SLC6A2-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 60 | DBH+SLC6A2-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 61 | DBH+SLC6A2-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 62 | DBH+SLC6A2-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
| 63 | DDC-HTR2B | - 5HT2B_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 64 | DDC-HTR4 | - 5HT4R_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 65 | DSG1-DSC3 | DSG1_HUMAN - DSC3_HUMAN | Adhesion-Adhesion | Adhesion by Desmosome |
| 66 | EFNB1-EPHA4 | EFNB1_HUMAN - EPHA4_HUMAN | Ligand-Receptor | Signaling by Ephrin |
| 67 | FGF1-FGFR2 | FGF1_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 68 | FGF10-FGFR2 | FGF10_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 69 | FGF2-FGFR2 | FGF2_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 70 | FGF22-FGFR2 | FGF22_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 71 | FGF3-FGFR2 | FGF3_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 72 | FGF7-FGFR2 | FGF7_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
| 73 | GAD1+SLC32A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 74 | GAD1+SLC6A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 75 | GAD1+SLC6A11-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 76 | GAD1+SLC6A12-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 77 | GAD1+SLC6A13-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 78 | GAD1+SLC6A6-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 79 | GAD1+SLC6A8-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 80 | GAD2+SLC32A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 81 | GAD2+SLC6A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 82 | GAD2+SLC6A11-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 83 | GAD2+SLC6A12-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 84 | GAD2+SLC6A13-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 85 | GAD2+SLC6A6-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 86 | GAD2+SLC6A8-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
| 87 | GAS6-MERTK | GAS6_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Growth arrest |
| 88 | GDF3-ACVR1B+ACVR2B | GDF3_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 89 | HSD17B1-ESR1 | - ESR1_HUMAN | Ligand-Receptor | Signaling by Estradiol |
| 90 | HSD17B1-GPER1 | - GPER1_HUMAN | Ligand-Receptor | Signaling by Estradiol |
| 91 | LGALS3-MERTK | LEG3_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Galectin |
| 92 | LGALS9-BCR+CD22+PTPRC | LEG9_HUMAN - | Ligand-Receptor | Signaling by Galectin |
| 93 | PDGFB-PDGFRA | PDGFB_HUMAN - PGFRA_HUMAN | Ligand-Receptor | Signaling by Platelet-derived growth factor |
| 94 | PDGFB-PDGFRA+PDGFRB | PDGFB_HUMAN - | Ligand-Receptor | Signaling by Platelet-derived growth factor |
| 95 | PDGFB-PDGFRB | PDGFB_HUMAN - PGFRB_HUMAN | Ligand-Receptor | Signaling by Platelet-derived growth factor |
| 96 | PF4-CXCR3 | PLF4_HUMAN - CXCR3_HUMAN | Ligand-Receptor | |
| 97 | POMC-MC1R | COLI_HUMAN - MSHR_HUMAN | Ligand-Receptor | Signaling by Podocalyxin-like protein |
| 98 | POMC-MC2R | COLI_HUMAN - ACTHR_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
| 99 | POMC-MC3R | COLI_HUMAN - MC3R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
| 100 | POMC-MC4R | COLI_HUMAN - MC4R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
| 101 | POMC-MC5R | COLI_HUMAN - MC5R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
| 102 | PRNP-ADGRG6 | APRIO_HUMAN - AGRG6_HUMAN | Ligand-Receptor | |
| 103 | PRXL2B-PTGFR | - PF2R_HUMAN | Ligand-Receptor | |
| 104 | PTHLH-PTH1R | PTHR_HUMAN - PTH1R_HUMAN | Ligand-Receptor | Signaling by Parathyroid hormone |
| 105 | PVR-CD96 | PVR_HUMAN - TACT_HUMAN | Ligand-Receptor | Signaling by Poliovirus receptor |
| 106 | SHMT1+SLC6A5-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
| 107 | SHMT1+SLC6A9-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
| 108 | SHMT2+SLC6A5-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
| 109 | SHMT2+SLC6A9-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
| 110 | SLIT2-ROBO1 | SLIT2_HUMAN - ROBO1_HUMAN | Ligand-Receptor | Signaling by SLIT and NTRK-like protein |
| 111 | TAFA5-FPR2 | TAFA5_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by TAFA |
| 112 | TAFA5-S1PR2 | TAFA5_HUMAN - S1PR2_HUMAN | Ligand-Receptor | Signaling by TAFA |
| 113 | TYR-GPR143 | - GP143_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 114 | UBASH3B-ESR1 | - ESR1_HUMAN | Ligand-Receptor | Signaling by Dehydroepiandrosterone |
| 115 | WNT1-FRZB | WNT1_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 116 | WNT1-FZD10+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 117 | WNT1-FZD10+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 118 | WNT1-FZD2+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 119 | WNT1-FZD2+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 120 | WNT1-FZD3+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 121 | WNT1-FZD3+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 122 | WNT1-FZD8+RYK | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 123 | WNT1-FZD9+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 124 | WNT1-FZD9+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 125 | WNT1-SFRP4 | WNT1_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 126 | WNT11-FRZB | WNT11_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 127 | WNT11-FZD10+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 128 | WNT11-FZD10+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 129 | WNT11-FZD2+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 130 | WNT11-FZD2+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 131 | WNT11-FZD3+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 132 | WNT11-FZD3+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 133 | WNT11-FZD9+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 134 | WNT11-FZD9+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 135 | WNT11-SFRP4 | WNT11_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 136 | WNT16-FRZB | WNT16_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 137 | WNT16-FZD10+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 138 | WNT16-FZD10+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 139 | WNT16-FZD2+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 140 | WNT16-FZD2+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 141 | WNT16-FZD3+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 142 | WNT16-FZD3+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 143 | WNT16-FZD9+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 144 | WNT16-FZD9+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 145 | WNT16-SFRP4 | WNT16_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 146 | WNT2-FRZB | WNT2_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 147 | WNT2-FZD10+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 148 | WNT2-FZD10+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 149 | WNT2-FZD2+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 150 | WNT2-FZD2+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 151 | WNT2-FZD3+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 152 | WNT2-FZD3+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 153 | WNT2-FZD9+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 154 | WNT2-FZD9+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 155 | WNT2-SFRP4 | WNT2_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 156 | WNT4-FRZB | WNT4_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 157 | WNT4-FZD10+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 158 | WNT4-FZD10+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 159 | WNT4-FZD2+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 160 | WNT4-FZD2+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 161 | WNT4-FZD3+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 162 | WNT4-FZD3+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 163 | WNT4-FZD9+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 164 | WNT4-FZD9+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
| 165 | WNT4-SFRP4 | WNT4_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |